| Literature DB >> 25136558 |
Haitao Zhu1, Jinlong Zhu1, Tiezhu Zhao2, Yong Wu1, Hongyi Liu1, Ting Wu3, Lu Yang3, Yuanjie Zou1, Rui Zhang1, Gang Zheng4.
Abstract
Resting MEG activities were compared between patients with left temporal lobe epilepsy (LTLE) and normal controls. Using SAMg2, the activities of MEG data were reconstructed and normalized. Significantly elevated SAMg2 signals were found in LTLE patients in the left temporal lobe and medial structures. Marked decreases of SAMg2 signals were found in the wide extratemporal lobe regions, such as the bilateral visual cortex. The study also demonstrated a positive correlation between the seizure frequency and brain activities of the abnormal regions after the multiple linear regression analysis. These results suggested that the aberrant brain activities not only were related to the epileptogenic zones, but also existed in other extratemporal regions in patients with LTLE. The activities of the aberrant regions could be further damaged with the increase of the seizure frequency. Our findings indicated that LTLE could be a multifocal disease, including complex epileptic networks and brain dysfunction networks.Entities:
Mesh:
Year: 2014 PMID: 25136558 PMCID: PMC4127284 DOI: 10.1155/2014/171487
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Demographic and clinical characteristics of the patients.
| Number | Age (Y)/gender | Age at onset (Y) | Seizure frequency/Mo | Duration of seizure (Mo) | MRI (lesion location) | Interictal MEG (SAMg2) | EEG (intro/extroperation) | Surgical procedure | Pathology | Follow-up (months)/outcome (Engle) |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 35/M | 23 | 4 | 12 | LT | LT | LT | Lesionectomy + ATL | LT cortical dysplasia | 35/IA |
| 2 | 30/M | 14 | 25 | 16 | NM | LT | LT (ant) | ATL | LT neurodegeneration | 46/IA |
| 3 | 23/F | 13 | 5 | 10 | LT | LT, LH | LT (ant, bas-lat) | ATL + SAH | LT neurodegeneration; LH HS | 35/IA |
| 4 | 21/M | 4 | 3 | 17.5 | LT, LH | LT, LH | LT (bas-lat) | ATL + SAH | LT gliosis; LH Atrophy | 29/IIA |
| 5 | 36/M | 32 | 4 | 4.5 | LT | LT | LT (lesion-pos) | Lesionectomy + ATL | LT angiomatosis | 39/IA |
| 6 | 21/F | 6 | 5 | 15 | LT | LT | LT (ant, bas-lat) | ATL + SAH | LT neurodegeneration; LH atrophy | 65/IB |
| 7 | 32/F | 22 | 12 | 10.5 | NM | LT, LH | LT (ant, bas-lat) | ATL + SAH | LT neurodegeneration; LH atrophy | 24/IA |
| 8 | 18/M | 9 | 5 | 9 | LT | LT | LT (lat, mid-inf) | Lesionectomy + ATL | LT ganglioneuroma | 60/1B |
| 9 | 38/F | 30 | 30 | 8.5 | LT | LT | LT (perilesion) | Lesionectomy + ATL | LT cortical dysplasia | 58/1A |
| 10 | 22/F | 2 | 4 | 20 | NM | LFT | LAT | ALT | NM | 37/IIA |
| 11 | 25/M | 16 | 7 | 9.5 | LT | LT | LT (lesion-pos) | Lesionectomy + ATL | LT cortical dysplasia | 26/IB |
| 12 | 29/M | 8 | 11 | 21 | NM | LT | LAT | ALT | LT neurodegeneration | 17/IIIB |
| 13 | 16/M | 2 | 3 | 14.5 | LT, LH | LT, LH | LT (ant, bas-lat) | ATL + SAH | LT neurodegeneration; LH atrophy | 22/IA |
| 14 | 22/F | 6 | 15 | 16 | LT | LT | LT | Lesionectomy + ATL | LT cortical dysplasia | 44/IA |
| 15 | 21/M | 11 | 22 | 10 | LT, LH | LT, LH | LT (ant, bas-lat) | ATL + SAH | LT gliosis; LH atrophy | 16/IA |
| 16 | 33/M | 27 | 28 | 6 | LT, LH | LTP, LH | LT (ant, bas-lat) | ATL + SAH | LT neurodegeneration; LH HS | 21/IA |
| 17 | 16/M | 4 | 6 | 12 | NM | LT, LH | LT (ant, bas-lat) | ATL + SAH | LT gliosis; LH atrophy | 15/IA |
| 18 | 25/M | 13 | 8 | 12 | LT | LT | LT | Lesionectomy + ATL | LT cortical dysplasia | 33/IA |
| 19 | 16/F | 3 | 2 | 13 | LT, LI | LT, LI | LAT, LI | ATL + SAH | LT neurodegeneration; LI atrophy | 38/IIC |
| 20 | 26/M | 15 | 6 | 11 | NM | LFT | LT (perilesion) | Lesionectomy + ATL | LT cortical dysplasia | 49/IB |
M: male; F: female; LT: left temporal; NM: normal; LH: left hippocampus; LI: left insular; LFT: left frontal-temporal; ant: anterior; bas: basal; lat: lateral; mid: middle; pos: post; inf: inferior; ATL: anterior temporal lobectomy; SAH: selective amygdalohippocampectomy; HS: hippocampal sclerosis.
Brain regions with increased and decreased activations in the patient group.
| Brain ROI | Voxels |
| MNI coordinate | ||
|---|---|---|---|---|---|
|
|
|
| |||
| Temporal_Mid_L | 270 | 4.15 | −48 | −33 | 0 |
| Hippocampus_L | 75 | 4.11 | −36 | −27 | −6 |
| Temporal_Sup_L | 179 | 4.1 | −45 | −36 | 6 |
| Temporal_Inf_L | 36 | 4.04 | −42 | −30 | −12 |
| Heschl_L | 38 | 3.96 | −39 | −21 | 6 |
| Insula_L | 87 | 3.89 | −39 | −18 | 0 |
| Fusiform_L | 92 | −2.03 | −24 | −75 | −3 |
| Precentral_R | 68 | −3.67 | 45 | −3 | 51 |
| Cerebelum_L | 310 | −3.71 | −18 | −72 | −12 |
| Cerebelum_R | 424 | −3.82 | 24 | −81 | −18 |
| Parietal_Sup_L | 38 | −3.86 | −15 | −69 | 42 |
| Precuneus_L | 242 | −4 | 0 | −66 | 30 |
| Occipital_Sup_L | 210 | −4.03 | −18 | −81 | 12 |
| Occipital_Inf_R | 129 | −4.04 | 30 | −81 | −6 |
| Occipital_Inf_L | 115 | −4.06 | −27 | −81 | 0 |
| Occipital_Mid_L | 295 | −4.07 | −27 | −75 | 0 |
| Precuneus_R | 405 | −4.14 | 15 | −66 | 24 |
| Occipital_Mid_R | 262 | −4.15 | 27 | −72 | 27 |
| Lingual_R | 554 | −4.19 | 24 | −75 | −3 |
| Calcarine_L | 533 | −4.3 | −21 | −72 | 6 |
| Occipital_Sup_R | 226 | −4.32 | 27 | −69 | 27 |
| Cuneus_L | 322 | −4.33 | 0 | −72 | 24 |
| Lingual_L | 456 | −4.37 | −21 | −72 | 3 |
| Fusiform_R | 159 | −4.44 | 27 | −75 | −6 |
| Calcarine_R | 474 | −4.44 | 24 | −75 | 9 |
| Cuneus_R | 335 | −4.49 | 21 | −69 | 27 |
L: left; R: right; Mid: middle; Sup: superior; Inf: inferior.
Figure 1Statistical parametric maps depict SAMg2 increases (warm colors) and decreases (cool colors) in LTLE compared with controls. Significant increases occur in left side hippocampal gyrus, insula, superior temporal gyrus, middle temporal gyrus, inferior temporal gyrus, and Heschl gyrus, while decreases occur in the bilateral calcarine, cerebellum, cuneus, fusiform, lingual gyrus, occipital lobe, precuneus, left parietal gyrus, and contralateral precentral gyrus.
Results of correlation analysis between the abnormal activity and the seizure frequency (P < 0.05 with FDR correction).
| Brain ROI |
|
|
|---|---|---|
| Precentral_R | 0.025 | 0.377 |
| Hippocampus_L | 0.025 | 0.406 |
| Calcarine_L | 0.025 | 0.373 |
| Calcarine_R | 0.027 | 0.349 |
| Cuneus_L | 0.021 | 0.474 |
| Cuneus_R | 0.026 | 0.357 |
| Lingual_R | 0.026 | 0.409 |
| Occipital_Sup_L | 0.031 | 0.488 |
| Occipital_Sup_R | 0.021 | 0.454 |
| Occipital_Mid_L | 0.025 | 0.383 |
| Occipital_Mid_R | 0.040 | 0.520 |
| Occipital_Inf_L | 0.022 | 0.441 |
| Occipital_Inf_R | 0.023 | 0.478 |
| Fusiform_L | 0.027 | 0.481 |
| Fusiform_R | 0.026 | 0.388 |
| Parietal_Sup_L | 0.022 | 0.431 |
| Precuneus_L | 0.022 | 0.459 |
| Precuneus_R | 0.027 | 0.389 |
| Temporal_Mid_L | 0.024 | 0.370 |
| Temporal_Inf_L | 0.033 | 0.577 |
| Cerebelum_L | 0.035 | 0.313 |
| Cerebelum_R | 0.028 | 0.517 |
L: left; R: right; Mid: middle; Sup: superior; Inf: inferior.